Table 1 Genotype frequencies for HFE mutations in controls, AD, PD and MCI patients
| Â | C282Y | Â | Â | p | H63D | Â | Â | p |
|---|---|---|---|---|---|---|---|---|
| Â | AA | GA | GG | Â | GG | CG | CC | Â |
Controls (n = 115) | 0 | 5 (4.3%) | 110 (95.7%) | Â | 2 (1.7%) | 39 (33.9%) | 74 (64.3%) | Â |
AD (n = 130) | 0 | 6 (4.6%) | 124 (95.4%) | 0.92 | 4 (3.1%) | 41 (31.5%) | 85 (65.4%) | 0.76 |
MCI (n = 55) | 0 | 3 (5.5%) | 52 (94.5%) | 0.75 | 3 (5.6%) | 18 (33.3%) | 33 (61.1%) | 0.39 |
PD (n = 132) | 0 | 18 (13.6%) | 114 (86.4%) | 0.01* | 5 (3.8%) | 38 (28.8%) | 89 (67.4%) | 0.47 |